University of Washington engineers, with spin-out company NanoFacture, have developed a device that can simply and efficiently extract human DNA from fluid samples, making it ready for analysis and genome sequencing in minutes. [ + ]

PathoGenetix, a commercial-stage developer of an automated system for rapid bacterial identification, has announced research demonstrating the use of genome sequence scanning (GSS) technology to confirm and identify pathogenic Salmonella strains in enriched spinach samples in less than 5 h. [ + ]

CSIRO scientists have developed the first safety test for iPS cells. [ + ]

ResMed (ASX:RMD) has launched a new online - and soon mobile - app to help sleep-disordered breathing patients track their therapy progress and set goals. [ + ]

Australian research has found that daily use of broad-spectrum sunscreen slows the ageing process of skin, as well as preventing skin cancer. [ + ]

A new Cooperative Research Centre (CRC) for Manufacturing Industry Innovation (MIICRC) invites organisations to participate as industry partners. [ + ]

Immuron (ASX:IMC) has dissolved its relationship with ANZ distributor Takeda and will start selling its flagship Travelan product directly to wholesalers in the markets. [ + ]

Research into a blowfly protein will not only enable farmers to design more effective pesticides, but it may also pave the way to an antidote for chemical warfare agents such as sarin gas. [ + ]

CSIRO Chairman Simon McKeon has announced that Chief Executive Dr Megan Clark has agreed to extend her term with the organisation to the end of 2014. [ + ]

Qiagen has announced two agreements adding promising new biomarkers involving glioblastoma, lymphoma and other cancers to the company’s expanding portfolio of potential companion diagnostics. [ + ]

Engineers at the University of Pennsylvania have used a pattern of nanoantennas to develop a new way of turning infrared light into mechanical action. [ + ]

The US FDA has added Pharmaxis’s Aridol to its Import Alert list, preventing the company from shipping units of the asthma test into the market. [ + ]

Biotron (ASX:BIT) will present data from its phase IIa trial of BIT225 in HIV at IAS 2013 in Malaysia. [ + ]

The Queensland Premier has announced significant funding support for dementia research. [ + ]

The University of Melbourne has been awarded $7.8 million over four years to establish the Centre of Excellence for Biosecurity Risk Analysis (CEBRA). [ + ]